The store will not work correctly when cookies are disabled.
(E)-3-(4-hydroxyphenyl)-1-(5-isobutylpyrazin-2-yl)prop-2-en-1-one
ID: ALA2288597
PubChem CID: 6474716
Max Phase: Preclinical
Molecular Formula: C17H18N2O2
Molecular Weight: 282.34
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)Cc1cnc(C(=O)/C=C/c2ccc(O)cc2)cn1
Standard InChI: InChI=1S/C17H18N2O2/c1-12(2)9-14-10-19-16(11-18-14)17(21)8-5-13-3-6-15(20)7-4-13/h3-8,10-12,20H,9H2,1-2H3/b8-5+
Standard InChI Key: YUXBARAKKNGZSH-VMPITWQZSA-N
Molfile:
RDKit 2D
21 22 0 0 0 0 0 0 0 0999 V2000
18.5257 -10.9206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5246 -11.7401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2326 -12.1491 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.9423 -11.7397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9394 -10.9170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2308 -10.5117 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.6456 -10.5058 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3549 -10.9117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6425 -9.6886 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.0610 -10.5004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7703 -10.9063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7702 -11.7224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4787 -12.1283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1858 -11.7169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1801 -10.8955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4711 -10.4934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8956 -12.1219 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.8165 -12.1482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8159 -12.9654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1079 -13.3734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5233 -13.3745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
7 9 2 0
8 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
14 17 1 0
2 18 1 0
18 19 1 0
19 20 1 0
19 21 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 282.34 | Molecular Weight (Monoisotopic): 282.1368 | AlogP: 3.28 | #Rotatable Bonds: 5 |
Polar Surface Area: 63.08 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.03 | CX Basic pKa: ┄ | CX LogP: 3.10 | CX LogD: 3.09 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.67 | Np Likeness Score: -0.03 |
References
1. Opletalová V, Hartl J, Patel A, Palát K, Buchta V.. (2002) Ring substituted 3-phenyl-1-(2-pyrazinyl)-2-propen-1-ones as potential photosynthesis-inhibiting, antifungal and antimycobacterial agents., 57 (2): [PMID:11902656] [10.1016/s0014-827x(01)01187-9] |